carmustine has been researched along with ATLL in 3 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komizu, Y | 1 |
Yukihara, M | 1 |
Kariya, R | 1 |
Goto, K | 1 |
Okada, S | 1 |
Ueoka, R | 1 |
Brito-Babapulle, F | 1 |
Arya, R | 1 |
Griffiths, T | 1 |
Pagliuca, A | 1 |
Mufti, GJ | 1 |
Jackson, NC | 1 |
Jackson, H | 1 |
Bock, M | 1 |
Ramsden, C | 1 |
Sharma, HL | 1 |
3 other studies available for carmustine and ATLL
Article | Year |
---|---|
Selective accumulation of hybrid liposomes into adult T-cell leukemia cells along with induction of apoptosis.
Topics: Apoptosis; Carmustine; Cells, Cultured; Dimyristoylphosphatidylcholine; Drug Delivery Systems; Hexos | 2011 |
BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Therapy, Combination; E | 1992 |
Cell-targeted 114Inm and drug (BCNU) combination therapy in a rat acute lymphoblastic leukaemia.
Topics: Animals; Carmustine; Combined Modality Therapy; Female; Indium Radioisotopes; Leukemia-Lymphoma, Adu | 1992 |